Previous 10 | Next 10 |
2024-02-25 17:35:04 ET Major earnings expected after the bell on Monday include: Zoom Video Communications ( ZM ) Unity Software ( U ) ONEOK ( OKE ) Innovative Industrial Properties ( IIPR ) Workday ( WDAY ) Read the full article on Seeking ...
2024-02-23 17:35:15 ET More on STAAR Surgical STAAR Surgical: Slowly Coming In My Sight STAAR Surgical collaborates with SharpeVision in the U.S. STAAR Surgical forecasts 2024 net sales between $335M - $340M Seeking Alpha’s Quant Rating on STAAR Surgic...
Kajima Corporation ADR (KAJMY) is expected to report for quarter end 2023-12-31 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 BrewBilt MFG Inc (BBRW) is expected to report for Q4 2023 Correlate Energy Corp. (CIPI) is expected to report for Q4 2023 Hyzon Motors Inc. (...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that it will release financial results for the fourth quarter ending Decem...
2024-02-15 01:30:00 ET Summary Vision Capital is fundamental-driven, bottom-up, and only focuses on investing in long-only publicly-listed equities. For 2023, Vision Capital returned +69.9% versus the S&P 500’s +24.0%. A large majority of our holdings were sold off ...
2024-02-12 23:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-02 07:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-23 07:33:08 ET More on STAAR Surgical STAAR Surgical: Slowly Coming In My Sight STAAR Surgical Company (STAA) Q3 2023 Earnings Call Transcript STAAR Surgical forecasts 2024 net sales between $335M - $340M STAAR Surgical Q3 2023 Earnings Preview ...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, and SharpeVision, a premier ophthalmology group with clinics in Seattle, Chicago and Austin, today...
2024-01-16 13:12:52 ET Summary RxSight reported preliminary Q4 results, capping off a record year for growth where sales climbed by approximately 82%. The company is capturing strong demand for its adjustable intraocular lens technology for cataract and lens replacement surgery. ...
News, Short Squeeze, Breakout and More Instantly...
STAAR Surgical Company Company Name:
STAA Stock Symbol:
NASDAQ Market:
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
2024-04-05 10:13:16 ET STAAR Surgical (NASDAQ: STAA) received an upgrade from William Blair on Friday. The stock has been moved from Market Perform to Outperform status. STAAR Surgical shares rose by over 13% on Thursday after the company issued strong preliminary first-quar...
2024-04-05 00:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...